Sun Pharmaceutical Industries Limited has been penalized by the Assistant Commissioner, Goods & Service Tax, Division, Mohali-I, Punjab, according to a recent stock exchange filing. The penalty, amounting to ₹35,43,766, was imposed under Section 74 of the GST Act, 2017.
The demand was issued in relation to unpaid taxes on specific recoveries made during the period from July 2017 to March 2020. This action underscores the ongoing scrutiny of tax compliance within the pharmaceutical industry and highlights the importance of adhering to GST regulations.
Sun Pharmaceutical is expected to review the order and determine its next steps in addressing the penalty. The company’s commitment to compliance will be crucial as it navigates this financial obligation amidst an evolving regulatory landscape.